Simultaneous targeting of mitochondrial metabolism and immune checkpoints as a new strategy for renal cancer therapy
Clin Transl Med
.
2022 Mar;12(3):e645.
doi: 10.1002/ctm2.645.
Authors
Sona Stemberkova-Hubackova
1
,
Renata Zobalova
1
,
Maria Dubisova
1
2
,
Jana Smigova
2
,
Sarka Dvorakova
1
,
Klara Korinkova
1
2
,
Zuzana Ezrova
1
,
Berwini Endaya
1
3
,
Kristyna Blazkova
1
,
Erik Vlcak
4
,
Petra Brisudova
1
,
Dan-Diem Thi Le
1
,
Stefan Juhas
5
,
Daniel Rosel
2
,
Cristina Daniela Kelemen
1
2
,
Dana Sovilj
1
,
Eliska Vacurova
1
2
,
Tomas Cajka
6
,
Vlada Filimonenko
4
,
Lanfeng Dong
3
,
Ladislav Andera
1
,
Pavel Hozak
4
,
Jan Brabek
2
,
Zuzana Bielcikova
7
,
Jan Stursa
1
,
Lukas Werner
1
,
Jiri Neuzil
1
3
Affiliations
1
Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic.
2
Faculty of Science, Charles University, Prague 1, Czech Republic.
3
School of Pharmacy and Medical Science, Griffith University, Southport, Qld, Australia.
4
Institute of Molecular Genetics, Czech Academy of Sciences, Prague 4, Czech Republic.
5
Institute of Animal Physiology and Genetics, Czech Academy of Science, PIGMOD Centre, Libechov, Czech Republic.
6
Institute of Physiology, Czech Academy of Sciences, Prague 4, Czech Republic.
7
General University Hospital, Prague 1, Czech Republic.
PMID:
35352502
PMCID:
PMC8964933
DOI:
10.1002/ctm2.645
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Immunotherapy*
Kidney Neoplasms* / drug therapy
Associated data
EudraCT/EudraCT 2017-004441-25